Self-Assembling Peptide Microgels for Vascularized Tissue

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current methods for manufacturing vascularized tissue in regenerative medicine face challenges in recreating native tissue microarchitecture and suffer from limitations in biocompatibility and translational potential, with traditional top-down techniques and biomaterials often failing to support effective vascularization and cell growth.

Innovation Solution

The development of cell-laden microgels using self-assembly ultrashort peptides (SUPs) that form spherical structures with ECM-like topography, which can be fabricated using a microfluidic flow-focusing chip and used as microcarriers to promote vascularization in 3D tissue constructs.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Manufacturing precision

If traditional top-down fabrication techniques are used to manufacture vascularized tissue, then the manufacturing process is relatively simple, but the native tissue microarchitecture cannot be recreated

Engineering Contradiction:
Improvetissue microarchitectureVSAvoidfabrication technique
Core Design Contradiction:
Manufacturing precisionVSDevice complexity

Solution Approach 1:

The invention divides the tissue construction process into modular units - self-assembling peptide nanofibers that form discrete microgels, which then assemble into larger vascularized tissue constructs. This segmentation allows precise control over microarchitecture while maintaining fabrication simplicity through the self-organizing properties of the peptide building blocks.

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The peptide sequences are pre-designed with specific self-assembling properties that enable them to spontaneously form the desired nanofibrous microarchitecture without requiring complex post-fabrication processing. The microgels are pre-formed with embedded cells before being assembled into the final tissue construct, eliminating the need for subsequent structural modifications.

Inventive Principle:
Principle #10Preliminary action

2Manufacturing precision

If sacrificial ink is used to create vascular channels, then vascular channels can be formed, but the native tissue microarchitecture is not recreated

Engineering Contradiction:
Improvevascular channel structureVSAvoidbiomaterial requirements
Core Design Contradiction:
Manufacturing precisionVSEase of manufacture

Solution Approach 1:

The peptide-based microgels self-assemble into vascular channel structures through their intrinsic self-organizing properties, eliminating the need for sacrificial materials or complex channel-forming procedures. The peptides automatically organize into nanofibrous networks that create functional vascular channels when exposed to physiological conditions.

Inventive Principle:
Principle #25Self-service

Solution Approach 2:

The invention exploits changes in peptide conformation and self-assembly behavior in response to physiological parameters (pH, ionic strength, temperature) to trigger spontaneous formation of vascular channel structures. This parameter-driven self-organization replaces complex manufacturing steps with simple environmental conditioning.

Inventive Principle:
Principle #35Parameter changes

3Reliability

If naturally-derived biomaterials are used, then biocompatibility is improved, but immunogenicity and pathogen transmission risk increase

Engineering Contradiction:
ImprovebiocompatibilityVSAvoidimmunogenicity
Core Design Contradiction:
ReliabilityVSObject-affected harmful factors

Solution Approach 1:

The invention creates composite peptide structures that combine the biocompatibility of natural amino acid sequences with the safety and consistency of synthetic production. The peptides are designed to mimic natural extracellular matrix components while being produced through controlled chemical synthesis, eliminating immunogenicity and pathogen risks associated with natural extraction.

Inventive Principle:
Principle #40Composite materials

Solution Approach 2:

The use of short peptide sequences (rather than long natural protein chains) creates materials that are inherently safer - the short sequences are less likely to trigger immune responses or transmit pathogens, while still providing the necessary structural and functional properties for tissue engineering applications.

Inventive Principle:
Principle #27Cheap short-living objects (Disposable)

4Stability of the object's composition

If synthetic materials are used, then material consistency is improved, but biocompatibility requires functionalization or blending

Engineering Contradiction:
Improvematerial consistencyVSAvoidmaterial functionalization
Core Design Contradiction:
Stability of the object's compositionVSEase of manufacture

Solution Approach 1:

The peptide materials provide their own functionalization through self-assembly - the amino acid sequences automatically organize into nanofibrous structures with appropriate surface properties for cell interaction, eliminating the need for separate functionalization steps. The self-organizing peptides inherently provide both structural consistency and biological functionality.

Inventive Principle:
Principle #25Self-service

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The SUP-based cell-laden microgels provide a biocompatible and stable platform for cell growth, supporting improved cell viability and proliferation, and can be used to create vascularized tissue constructs with enhanced structural fidelity and biocompatibility, overcoming the limitations of existing biomaterials.

Implementation Method 1

at least one self-assembly ultrashort peptide (SUP) scaffold

Methodology Applied
Scientific EffectSelf-assembly: Self-Assembly

Implementation Method 2

fabricating cell-free microgel using the microfluidic flow-focusing chip

Methodology Applied
Scientific EffectFlow focusing: Focusing

Data Source

PatentUS20230382948A1Delivery of endothelial cell-laden microgel elicits angiogenesis in self-assembling ultrashort peptide hydrogels
Publication Date: 2023.11.30 KING ABDULLAH UNIV OF SCI & TECH
  • US20230382948A1 patent drawing
  • US20230382948A1 patent drawing
  • US20230382948A1 patent drawing

AI summary

The present disclosure relates to a cell-laden microgel comprising self-assembly ultrashort peptide (SUP) and a method of frabricating such cell-laden microgels. The present disclosure also relates to a cell microcarrier comprising cell-laden microgels, which is suitable for medical applications such as cell therapy. The present disclosure further relates to a system comprising a combination of SUP microgel and SUP bulk hydrogel for vascularized tissue culture and a method of creating such a vascularized 3D tissue constructs with improved cell viability and proliferation.